Skywalker-TBC1D24 has a lipid-binding pocket mutated in epilepsy and required for synaptic function.

TitleSkywalker-TBC1D24 has a lipid-binding pocket mutated in epilepsy and required for synaptic function.
Publication TypeJournal Article
Year of Publication2016
AuthorsFischer, B., Lüthy K., Paesmans J., De Koninck C., Maes I., Swerts J., Kuenen S., Uytterhoeven V., Verstreken P., and Versées W.
JournalNat Struct Mol Biol
Volume23
Issue11
Pagination965-973
Date Published2016 Nov
ISSN1545-9985
Abstract

Mutations in TBC1D24 cause severe epilepsy and DOORS syndrome, but the molecular mechanisms underlying these pathologies are unresolved. We solved the crystal structure of the TBC domain of the Drosophila ortholog Skywalker, revealing an unanticipated cationic pocket conserved among TBC1D24 homologs. Cocrystallization and biochemistry showed that this pocket binds phosphoinositides phosphorylated at the 4 and 5 positions. The most prevalent patient mutations affect the phosphoinositide-binding pocket and inhibit lipid binding. Using in vivo photobleaching of Skywalker-GFP mutants, including pathogenic mutants, we showed that membrane binding via this pocket restricts Skywalker diffusion in presynaptic terminals. Additionally, the pathogenic mutations cause severe neurological defects in flies, including impaired synaptic-vesicle trafficking and seizures, and these defects are reversed by genetically increasing synaptic PI(4,5)P2 concentrations through synaptojanin mutations. Hence, we discovered that a TBC domain affected by clinical mutations directly binds phosphoinositides through a cationic pocket and that phosphoinositide binding is critical for presynaptic function.

DOI10.1038/nsmb.3297
Alternate JournalNat. Struct. Mol. Biol.
PubMed ID27669036
Research group: